These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9486552)

  • 1. Treatment of suprachoroidal hemorrhage with tissue plasminogen activator.
    Kwon OW; Kang SJ; Lee JB; Lee SC; Yoon YD; Oh JH
    Ophthalmologica; 1998; 212(2):120-5. PubMed ID: 9486552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental suprachoroidal hemorrhage with subconjunctival injection of tissue plasminogen activator: a negative report.
    Liu JC; Peyman GA; Oncel M
    Ophthalmic Surg; 1990 Sep; 21(9):641-3. PubMed ID: 2123529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of experimental suprachoroidal hemorrhage with intravenous tissue plasminogen activator.
    Liu JC; Peyman GA; Oncel M
    Int Ophthalmol; 1990 Jul; 14(4):267-70. PubMed ID: 2115030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model.
    Boone DE; Boldt HC; Ross RD; Folk JC; Kimura AE
    Retina; 1996; 16(6):518-24. PubMed ID: 9002136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage.
    Coll GE; Sparrow JR; Marinovic A; Chang S
    Retina; 1995; 15(4):319-26. PubMed ID: 8545578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tissue plasminogen activator on premacular hemorrhage.
    Chung J; Kim MH; Chung SM; Chang KY
    Ophthalmic Surg Lasers; 2001; 32(1):7-12. PubMed ID: 11195747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage.
    Johnson MW; Olsen KR; Hernandez E
    Ophthalmology; 1992 Apr; 99(4):515-21. PubMed ID: 1584568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue plasminogen activator in the treatment of vitreoretinal diseases.
    Kamei M; Estafanous M; Lewis H
    Semin Ophthalmol; 2000 Mar; 15(1):44-50. PubMed ID: 10749314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte-Inspired Discoidal Polymeric Nanoconstructs Carrying Tissue Plasminogen Activator for the Enhanced Lysis of Blood Clots.
    Colasuonno M; Palange AL; Aid R; Ferreira M; Mollica H; Palomba R; Emdin M; Del Sette M; Chauvierre C; Letourneur D; Decuzzi P
    ACS Nano; 2018 Dec; 12(12):12224-12237. PubMed ID: 30427660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
    Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA
    Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenylpropanoid micronutrient chlorogenic acid improves clinical rating scores in rabbits following multiple infarct ischemic strokes: synergism with tissue plasminogen activator.
    Lapchak PA
    Exp Neurol; 2007 Jun; 205(2):407-13. PubMed ID: 17439814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of failing glaucoma filtering cystic blebs with tissue plasminogen activator (tPA).
    Lee PF; Myers KS; Hsieh MM; Wood EF; Hotaling DM
    J Ocul Pharmacol Ther; 1995; 11(3):227-32. PubMed ID: 8590254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage.
    Kunjukunju N; Gonzales CR; Rodden WS
    Clin Ophthalmol; 2011; 5():155-7. PubMed ID: 21383941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator treatment of experimental subretinal hemorrhage.
    Lewis H; Resnick SC; Flannery JG; Straatsma BR
    Am J Ophthalmol; 1991 Feb; 111(2):197-204. PubMed ID: 1899537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous suprachoroidal hemorrhage secondary to thrombolysis for the treatment of myocardial infarction.
    Barsam A; Heatley CJ; Herbert L
    Clin Exp Ophthalmol; 2006 Mar; 34(2):177-9. PubMed ID: 16626438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clot penetration and retention by plasminogen activators promote fibrinolysis.
    Marcos-Contreras OA; Ganguly K; Yamamoto A; Shlansky-Goldberg R; Cines DB; Muzykantov VR; Murciano JC
    Biochem Pharmacol; 2013 Jan; 85(2):216-22. PubMed ID: 23098998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator as a biochemical adjuvant in vitrectomy for proliferative diabetic vitreoretinopathy.
    Hesse L; Chofflet J; Kroll P
    Ger J Ophthalmol; 1995 Nov; 4(6):323-7. PubMed ID: 8751095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage secondary to retinal artery macroaneurysm.
    Wu TT; Sheu SJ
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):62-7. PubMed ID: 15718829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating subretinal hemorrhage with tissue plasminogen activator.
    Hesse L
    Arch Ophthalmol; 2002 Jan; 120(1):102-3; author reply 203. PubMed ID: 11786077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.